Cargando…
Translational Pharmacokinetic‐Pharmacodynamic Modeling and Simulation: Optimizing 5‐Fluorouracil Dosing in Children With Pediatric Ependymoma
We previously investigated novel therapies for pediatric ependymoma and found 5‐fluorouracil (5‐FU) i.v. bolus increased survival in a representative mouse model. However, without a quantitative framework to derive clinical dosing recommendations, we devised a translational pharmacokinetic‐pharmacod...
Autores principales: | Daryani, VM, Patel, YT, Tagen, M, Turner, DC, Carcaboso, AM, Atkinson, JM, Gajjar, A, Gilbertson, RJ, Wright, KD, Stewart, CF |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834132/ https://www.ncbi.nlm.nih.gov/pubmed/27104090 http://dx.doi.org/10.1002/psp4.12075 |
Ejemplares similares
-
Population Pharmacokinetics of Selumetinib and Its Metabolite N‐desmethyl‐selumetinib in Adult Patients With Advanced Solid Tumors and Children With Low‐Grade Gliomas
por: Patel, YT, et al.
Publicado: (2017) -
Effect of Ketorolac on Pharmacokinetics and Pharmacodynamics of 5-Fluorouracil: In Vivo and In Vitro Study
por: Atefinezhad, Motahare, et al.
Publicado: (2022) -
Stem cells of ependymoma
por: Poppleton, H, et al.
Publicado: (2007) -
A model for research initiatives for rare cancers: the collaborative ependymoma research network (CERN)
por: Armstrong, T S, et al.
Publicado: (2014) -
Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases.
por: Goldberg, J. A., et al.
Publicado: (1988)